Elsevier

Value in Health

Volume 19, Issue 7, November 2016, Page A469
Value in Health

PHP168 - Early Market Access for Pharmaceuticals in EU: What is the Impact of Ema’s Accelerated Assessment Procedure?

https://doi.org/10.1016/j.jval.2016.09.710Get rights and content
Under an Elsevier user license
open archive

Cited by (0)